EUVIMEDEUVIMED entdecken
Leitlinie

Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia

Nadine C M van Huijgevoort, Sanne A M Hoogenboom, Selma J Lekkerkerker, Olivier R Busch, Marco Del Chiaro, Paul Fockens, Inne Somers, Joanne Verheij, Rogier P Voermans, Marc G Besselink, Jeanin E van Hooft

Pancreatology · 2023

DOI: 10.1016/j.pan.2023.01.011 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Pancreatology, 2023. Verfasst von Nadine C M van Huijgevoort und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Pancreatic Intraductal Neoplasms, Pancreatic Cyst, Pancreatic Neoplasms, Neoplasms, Cystic, Mucinous, and Serous. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Follow-up in patients with intraductal papillary mucinous neoplasm (IPMN) aims to detect advanced neoplasia (high-grade dysplasia/cancer) in an early stage. The 2015 American Gastroenterological Association (AGA), 2017 International Association of Pancreatology (IAP), and the 2018 European Study Group on Cystic tumours of the Pancreas (European) guidelines differ in their recommendations on indications for surgery. However, it remains unclear which guideline is most accurate in predicting advanced neoplasia in IPMN. METHODS: Patients who underwent surgery were extracted from a prospective database (January 2006-January 2021). In patients with IPMN, final pathology was compared with the indication for surgery according to the guidelines. ROC-curves were calculated to determine the diagnostic accuracy for each guideline. RESULTS: Overall, 247 patients underwent surgery for cystic lesions. In 145 patients with IPMN, 52 had advanced neoplasia, of which the AGA guideline would have advised surgery in 14 (27%), the IAP and European guideline in 49 (94%) and 50 (96%). In 93 patients without advanced neoplasia, the AGA, IAP, and European guidelines would incorrectly have advised surgery in 8 (8.6%), 77 (83%) and 71 (76%). CONCLUSION: The European and IAP guidelines are clearly superior in detecting advanced neoplasia in IPMN as compared to the AGA, albeit at the cost of a higher rate of unnecessary surgery. To harmonize care and to avoid confusion caused by conflicting statements, a global evidence-based guideline for PCN in collaboration with the various guidelines groups is required once the current guidelines require an update.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Intraductal NeoplasmsPancreatic CystPancreatic NeoplasmsNeoplasms, Cystic, Mucinous, and SerousCarcinoma, Pancreatic DuctalHumansPancreasRetrospective Studies

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Department of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Radiology, Amsterdam UMC, University of Amsterdam, the Netherlands; Department of Radiology, Meander Medical Center, Amersfoort, the Netherlands.
  • Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: J.E.van_Hooft@lumc.nl.

Zitieren

APA

van Huijgevoort, N. C. M., Hoogenboom, S. A. M., Lekkerkerker, S. J., Busch, O. R., Del Chiaro, M., Fockens, P., Somers, I., Verheij, J., Voermans, R. P., Besselink, M. G., & van Hooft, J. E. (2023). Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia. Pancreatology. https://doi.org/10.1016/j.pan.2023.01.011

Vancouver

van Huijgevoort NCM, Hoogenboom SAM, Lekkerkerker SJ, Busch OR, Del Chiaro M, Fockens P, et al. Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia. Pancreatology. 2023. doi:10.1016/j.pan.2023.01.011

BibTeX
@article{vanHuijgevoort2023,
  author = {van Huijgevoort, Nadine C M and Hoogenboom, Sanne A M and Lekkerkerker, Selma J and Busch, Olivier R and Del Chiaro, Marco and Fockens, Paul and Somers, Inne and Verheij, Joanne and Voermans, Rogier P and Besselink, Marc G and van Hooft, Jeanin E},
  title = {Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia},
  journal = {Pancreatology},
  year = {2023},
  doi = {10.1016/j.pan.2023.01.011}
}
Kostenlos starten →